Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment publishing date : 2021 - 10 - 07 save search
Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Granted Rare Pediatric Disease Designation by FDA
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 0.97%
H: 3.54%
C: -1.49%
disease treatment fda rare pediatric disease designation granted designation rare
BridgeBio Pharma Announces First Publication of Preclinical Data for its Potentially Best-in-Class SHP2 Inhibitor Designed for Treatment of Resistant Cancer, Showing Response in Established Non-small Cell Lung Cancer Models
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
BBIO | $25.02 -1.73% -1.76% 1.5M
|
Health Technology
|
| O: 0.2%
H: 3.57%
C: -0.56%
treatment lung cancer potential cancer preclinical pre-clinical designation
LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 21:00) - biospace.com/
LVTX | $2.77 -7.05% -7.58% 150K
|
|
| O: -3.3%
H: 5.92%
C: 0.77%
treatment molecular cancer conference t-cell
CORRECTING and REPLACING: LAVA Therapeutics to Present its Bispecific Gamma Delta T Cell Engagers for Treatment of Cancer at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-10-07 (Crawled : 18:00) - globenewswire.com
LVTX | $2.77 -7.05% -7.58% 150K
|
|
| O: -3.3%
H: 5.92%
C: 0.77%
treatment molecular cancer conference t-cell
Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
GLUE | $5.46 -1.44% -1.47% 83K
|
Professional, Scientific, and T...
|
| O: 0.1%
H: 3.64%
C: -2.44%
treatment rosa potential molecular cancer preclinical pre-clinical
Ikena Oncology Presents Data at AACR-NCI-EORTC Virtual Conference Demonstrating Potential of TEAD Inhibitors in Cancer Treatment
Published: 2021-10-07 (Crawled : 13:15) - globenewswire.com
IKNA | $1.31 -2.96% -3.05% 150K
|
Manufacturing
|
| O: 0.28%
H: 11.59%
C: 8.9%
treatment potential cancer conference
Acumen Announces First Patient Dosed in a Phase 1 Clinical Trial of ACU193, a Monoclonal Antibody that Selectively Targets Toxic Aβ Oligomers for the Treatment of Early Alzheimer’s Disease
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
ABOS | $3.17 0.32% 0.32% 150K
|
Professional, Scientific, and T...
|
| O: 0.81%
H: 0.0%
C: -1.14%
disease alzheimer treatment phase 1 antibody trial aβos alzheimer’s alzheimer's disease alzheimer's
Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated Meningiomas
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
RXRX | $7.94 3.12% 3.02% 7.1M
|
Professional, Scientific, and T...
|
| O: 1.68%
H: 7.18%
C: 6.38%
treatment fda fda fast track potential fast track granted rec-2282 fast track designation designation
Editas Medicine to Present Preclinical Data on Novel Engineered iPSC Derived NK Cells for the Treatment of Cancer at the Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
EDIT | News | $5.355 -1.92% -1.96% 1.6M
|
Health Technology
|
| O: 0.99%
H: 5.99%
C: 2.95%
treatment immunotherapy therapy cancer preclinical pre-clinical
Cerevel Therapeutics Hosts Virtual R&D Event to Review CVL-871 in Dementia-Related Apathy and Provide Update on CVL-231 for the Treatment of Schizophrenia
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
CERE | $41.87 -0.29% -0.29% 630K
|
Finance
|
| O: -0.58%
H: 6.21%
C: 5.99%
treatment dementia schizophrenia
Ocuphire Announces Publications Featuring the Ref-1 Protein, a Transcription Factor Regulator, as a Novel Therapeutic Target for the Treatment of Neovascular Retinal Diseases
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
OCUP | News | $1.52 -1.3% -1.32% 90K
|
Health Technology
|
| O: 0.0%
H: 3.7%
C: -1.35%
disease treatment retina
Tendonitis Treatment Market Size Worth $235.4 Billion By 2028: Grand View Research, Inc.
Published: 2021-10-07 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.4%
H: 0.1%
C: 0.1%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.42%
H: 1.4%
C: 0.97%
treatment research
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.